Eyenovia MiDD Usability Study

• Status: Completed
• Trial end date: 2018-03-17

Summary

This study is to evaluate the usability and patient tolerability for microtherapeutic dosing of commercially available ocular medication via the Eyenovia microdose delivery system (MiDD)

• Phase: N/A

Details

• Lead Sponsor: Eyenovia Inc.
• Treatments: Latanoprost; Ophthalmic Solutions; Pharmaceutical Solutions